Category Archives: Corporate

Latest From Corporate

Send us Your BIO 2016 Session and Speaker Ideas

BIO International Convention

Even though BIO 2015 in Philadelphia was just two months ago, we already are hard at work getting ready for 2016 and the BIO International Convention in San Francisco (June 6-9, 2016). Our team at BIO is always imagining new ways to improve your experience, to make the most of your time and your meetings and to ensure that you are hearing directly from the key science, policy and investment leaders that allow you to Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: ,

Jeanne Haggerty Heads up BIO’s Fed Gov Team

Biotechnology Industry Organization (BIO)

BIO is proud to announce the promotion of Jeanne Haggerty to Senior Vice President for Federal Government Relations. Haggerty has been with us at BIO since 2006, but before coming to BIO she graduated with a B.A. in Political Science and English from the University of Vermont, then went on to work on Capitol Hill for the House Energy and Commerce Committee. Read the Press Release here. In her free time, Haggerty works with rescue organizations Read More >

Corporate  |  Leave a comment  |  Email This Post
Tags:

Jim Greenwood asks: How prepared are we for avian flu?

Jim Greenwood

As a serious avian influenza outbreak continues to wreak havoc on poultry farms across the U.S., one question that is beginning to draw attention from lawmakers and others centers on our ability to respond should the virus begin to infect humans. BIO President and CEO Jim Greenwood explored that issue in an op-ed yesterday at The Hill: The prospect of HPAI [Highly Pathogenic Avian Influenza] spreading to humans recently drew the attention of bipartisan leaders Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Welcome to Philadelphia and to BIO 2015!

Jim Greenwood

Over the course of the next few days, you will have the opportunity to hear from leaders from across our industry and to make the types of connections and partnerships that will take your business and your science to the next level. I am particularly looking forward to a wide ranging conversation with legendary journalist Tom Brokaw and a keynote session on digital health and the future of medical innovation with Dr. Eric Topol. We also Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , ,

Jim Greenwood in New York Times: Specialty Tiers Limit Patient Access

Jim Greenwood

Today, the New York Times published a letter from Jim Greenwood, BIO’s President and CEO. Greenwood’s letter discusses the problems that expanded use of specialty tier cost-sharing by the insurance industry are posing for patients, limiting their access to lifesaving therapies and cures. Breakthrough treatments cost billions of dollars, and investors will only take on such risks if they can expect a reasonable return on their investment. The full text of the letter is below: To Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,